-
| ISIN | US00534B1008 |
|---|---|
| Sector | Healthcare |
| Industry | Medical Devices |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| Market Cap | 55M |
|---|---|
| Beta | -0.03 |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ADGM using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025